Indian healthtech firms now fairly valued amid market shift, says Leapfrog exec

Indian healthtech firms now fairly valued amid market shift, says Leapfrog exec

Biju Mohandas, Leapfrog Investments

02 October, 2024

Edited by: Padma Priya

Goodlife Pharmacy HealthifyMe LeapFrog Investments MedGenome Redcliffe Labs Temasek

Printed by Unregistered user on Tue, 18 Nov 2025 10:02:43 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

IFC weighs $30m investment in LeapFrog's latest climate fund

Need to shift more climate investments to countries like India: LeapFrog

Read more from India

Ascertis Credit makes $520m first close of $1b Asia private credit fund

Indian edtech firm PhysicsWallah hits $5b valuation as stock soars 45% in market debut